Spots Global Cancer Trial Database for nasopharynx cancer
Every month we try and update this database with for nasopharynx cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma | NCT04004871 | Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Can... | Nab-paclitaxel,... concurrent chem... | 18 Years - 60 Years | Guangxi Medical University | |
Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) | NCT03682055 | Nasopharyngeal ... Nasopharyngeal ... | VK-2019 | 18 Years - | Cullinan Therapeutics Inc. | |
Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) | NCT03682055 | Nasopharyngeal ... Nasopharyngeal ... | VK-2019 | 18 Years - | Cullinan Therapeutics Inc. | |
Adaptive Radiotherapy for Head and Neck Cancer | NCT03096808 | Head and Neck C... Paranasal Sinus... Oropharynx Canc... Oral Cavity Can... Nasopharynx Can... Larynx Cancer Hypopharynx Can... | Adaptive Radiot... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx | NCT00797290 | Nasopharynx Can... | 18 Years - | University of Florida | ||
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | NCT03082534 | HNSCC Lip SCC Oral Cavity Can... Oropharynx Canc... Larynx Cancer Hypopharynx Can... Nasopharynx Can... Sinonasal Carci... Cutaneous Squam... Head and Neck N... Head and Neck C... Head and Neck S... | Pembrolizumab, ... | 18 Years - | University of California, San Diego | |
Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies | NCT04925544 | Nasopharyngeal ... Epstein-Barr Vi... | VK-2019 | 18 Years - | Stanford University | |
Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx | NCT00797290 | Nasopharynx Can... | 18 Years - | University of Florida | ||
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | NCT06019130 | Nasopharyngeal ... Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Can... | Nivolumab Cisplatin 5-Fluorouracil Gemcitabine Radiotherapy Interferon beta... MRI PET Patient-Reporte... | 3 Years - | German Society for Pediatric Oncology and Hematology GPOH gGmbH | |
Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies | NCT04925544 | Nasopharyngeal ... Epstein-Barr Vi... | VK-2019 | 18 Years - | Stanford University |